The increasing incidence of respiratory diseases and the rising number of admissions to emergency units in hospitals are among the prominent factors driving the arterial blood gas kits market growth. However, the high cost of kits and complications associated with arterial blood sampling is hampering the growth of the market.

Development of Safe & Automated Kits and Integration of Electronic Medical Records Expected to Bring New Arterial Blood Gas Kits Market Trends

Arterial blood gas kits can be equipped with wireless connectivity options, due to which they can be seamlessly integrated with the electronic medical records (EMR) of a hospital information system (HIS). The integration revolutionizes the diagnostic process, empowering healthcare providers with immediate data insights and enabling timely interventions that enhance patient management and clinical decision-making. The burgeoning popularity of telehealth and remote monitoring activities further encourages companies to focus on developing kits that are user-friendly so that they can reduce human errors and improve the overall usability of the product. They are incorporating automated quality control mechanisms and calibration processes in kits to minimize errors and maintain consistent performance of kits. The companies may also integrate kits with safety features such as sample volume monitoring, built-in error detection algorithms, and automatic system checks to ensure the reliability of arterial blood gas kits. In addition, arterial blood gas kits can be introduced with integrated sensors and analyzers that can easily and accurately measure parameters such as partial pressure of oxygen (pO2), electrolytes, partial pressure of carbon dioxide (pCO2), and pH. Thus, the development of user-friendly and automated kits, and the integration of EMR with them are likely to emerge as a notable trend in the arterial blood gas kits market in the future.

Based on geography, the Arterial Blood Gas Kits market is segmented into North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). The US held the largest share of the market in North America in 2023. According to the Asthma and Allergy Foundation of America, ~26 million people in the US had asthma in 2022, one of the world’s most common respiratory diseases. Respiratory infections cause more severe disease, leading to hospitalizations or death. Mortality is more common in older persons than in younger ones due to age-related issues such as frailty and immunosenescence. Asthma is one of the most common respiratory diseases among senior citizens. According to the 2020 Census, the geriatric population reached 55.8 million (16.8%) of the total US population in 2020, and it is projected to rise significantly during 2012–2050. These individuals need a greater understanding of the impacts of respiratory diseases on their health, as patients suffering from respiratory disorders usually experience breathing issues due to oxygen shortage. Arterial blood gas analysis evaluates dissolved oxygen and carbon dioxide content in the form of partial oxygen pressures (PaO2) and partial carbon dioxide pressures (PaCO2), respectively, in the arterial blood of patients. PaCO2 gives information on ventilation status (acute or chronic respiratory failure), while PaO2 provides insights into oxygenation status.

The growing prevalence of chronic diseases necessitating arterial blood gas analysis, including respiratory failure, acute respiratory distress syndrome (ARDS), asthma, diabetic ketoacidosis, renal tubular acidosis, heart failure (HF), and congenital metabolic diseases, is the major factor contributing to the largest share of the US in the arterial blood gas kits market. Moreover, the country’s well-established position in terms of technological advancements contributes notably to the availability of various arterial blood gas kits and associated technologies.

The arterial blood gas kits market has been segmented on the basis of syringe type, type, usage, application, needle gauge, syringe volume, and end user.

The arterial blood gas kits market, by syringe type, is bifurcated into Luer slip syringe and Luer lock syringe. The Luer lock syringe segment held a larger share in the arterial blood gas kits market in 2023.

The arterial blood gas kits market, by type, is bifurcated into vented and non-vented. The vented segment held a larger share of the arterial blood gas kits market in 2023. Vented kits are commonly used when there is a need to collect large arterial blood samples or when the sample needs to be transported over a longer period before analysis.

The arterial blood gas kits market, by usage, is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger share in the arterial blood gas kits market in 2023.

The arterial blood gas kits market, by application, is bifurcated into in vitro diagnostics and electrolyte analysis. The vitro diagnostics segment is further segmented into pH blood gas, oxygen content, and others. The in vitro diagnostics segment held the largest share of the arterial blood gas kits market in 2023.

The arterial blood gas kits market, by syringe volume, is divided into 1 ml, 3 ml, and others. The 3 ml segment held the largest share in the arterial blood gas kits market in 2023.

The arterial blood gas kits market, by needle gauge, is divided into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held the largest share in the arterial blood gas kits market in 2023.

The arterial blood gas kits market, by end user, is divided into hospitals and clinics, diagnostic laboratories, and others. The hospitals and clinics segment held the largest share of the market in 2023.

Arterial Blood Gas Kits Market: Competitive Landscape and Key Developments

Radiometer Medical ApS, Vyaire Medical Inc, Opti Medical Systems, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC (AirLife), Trudell Healthcare Solutions Inc., SARSTEDT AG & Co KG, Lepu Medical Technology Beijing Co Ltd, and Levram Lifesciences Pvt. Ltd are among the leading companies profiled in the arterial blood gas kits market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to meet the surging demand from consumers worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large customer base, subsequently facilitating market expansion.